Patient Velocity is a healthcare startup that aims to revolutionize patient recruitment for clinical trials by leveraging the power of data science. The current patient recruitment methods have been insufficient in meeting study needs, given the statistics that 96% of the US population have never participated in a clinical trial, 90% of clinical trials fail to meet enrollment timelines, and one-third of Phase 3 studies are terminated due to enrollment challenges. This underscores the critical need for innovative solutions in this space. Patient Velocity has developed a unique technology solution that integrates data science best practices with automated solutions and digital marketing tailored specifically for patient recruitment in clinical trials. Notably, the company has successfully served some of the world's largest clinical research organizations and pharmaceutical companies, demonstrating its ability to activate a broad and diverse network, achieve higher quality results in less time, and enhance transparency through performance-based pricing. The startup has achieved several successes, including consistently ranking as one of the top 5 recruiting partners in terms of qualified referrals, meeting partners' compliance requirements and cost metrics, and earning the status as the preferred patient recruitment partner based on its track record of performance and compliance. Patient Velocity's innovative approach to patient recruitment in clinical trials positions it as a potentially compelling investment opportunity. For more information, interested parties can reach out to Patient Velocity via [email protected] or visit the company's website at https://patientvelocity.com/.
There is no investment information
No recent news or press coverage available for Patient Velocity.